APA (7th ed.) Citation

Laribi, K., Leleu, X., Texier, N., Germain, R., Touzeau, C., Hammoud, M., . . . Perrot, A. (2024). Real‐life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study. EJHaem, 5(1), 55-60. https://doi.org/10.1002/jha2.828

Chicago Style (17th ed.) Citation

Laribi, Kamel, et al. "Real‐life Effectiveness of Carfilzomib in Patients with Relapsed Multiple Myeloma Receiving Treatment in the Context of Early Access: The CARMYN Study." EJHaem 5, no. 1 (2024): 55-60. https://doi.org/10.1002/jha2.828.

MLA (8th ed.) Citation

Laribi, Kamel, et al. "Real‐life Effectiveness of Carfilzomib in Patients with Relapsed Multiple Myeloma Receiving Treatment in the Context of Early Access: The CARMYN Study." EJHaem, vol. 5, no. 1, 2024, pp. 55-60, https://doi.org/10.1002/jha2.828.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.